Borns Robot

About Borns Robot

Borns Medical Robotics Inc., formerly known as Borns Robot, is a medical device company established in 2016 with a focus on minimally invasive surgical robots and AI-driven medical technologies. The company was founded by Dr. Yao Li, a scientist from the Stanford University Artificial Intelligence Laboratory's Robotics Center. Dr. Li's background includes a Ph.D. in Electrical and Computer Engineering from the University of Maryland, College Park, and postdoctoral research in biomedical engineering at the University of Southern California, experiences that directly inform the company's direction. He is joined by co-founder and CTO, Dr. William Levine, an IEEE Life Fellow.

Operating with dual headquarters in Chengdu, China, and a US R&D center in Silicon Valley, the company aims to address the surgical needs of the Chinese market and beyond. Borns develops intelligent surgical robots featuring proprietary software platforms, flexible robotic arms, and precise electronic systems. A key product is the Simphoni Surgical Robotic System, an open-platform designed for an intuitive surgeon experience with HD 3D visualization. The company has also developed the TORSS, a flexible pharyngeal-laryngeal surgical robotic system. These systems target applications in urology, gynecology, and general surgeries such as hepatobiliary and pancreatic procedures. The business model centers on the design, manufacture, and distribution of these advanced robotic systems. The company's technology leverages vast amounts of real-time surgical data, including vital signs and intraoperative images, which a "surgical brain" uses deep learning to analyze, offering decision-making guidance to surgeons to enhance accuracy.

Borns has achieved significant milestones, holding over 350 patents and receiving recognition from the Ministry of Industry and Information Technology of China. In 2021, its intelligent robots passed the Special Review Procedure for Innovative Medical Devices by the National Medical Products Administration. The company has engaged in multiple funding rounds, including a Series B in April 2022, with investors such as DYEE Capital and Jiangsu Winfast Investment Holding Group. Strategic partnerships are a key component of its growth, including a collaboration with B. Braun that began in 2018 to integrate B. Braun's surgical instruments and 3D laparoscopic systems into Borns' robots, and to cooperate on training and marketing.